Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Q-linea AB's share price for the quarter that ended in Mar. 2026 was kr1610. Q-linea AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 18.95 Mil. Therefore, Q-linea AB's market cap for the quarter that ended in Mar. 2026 was kr30,507.89 Mil.
Q-linea AB's quarterly market cap
increased
from Sep. 2025 (kr11,097.73 Mil) to Dec. 2025 (kr30,507.89 Mil) but then
stayed the same
from Dec. 2025 (kr30,507.89 Mil) to Mar. 2026 (kr30,507.89 Mil).
Q-linea AB's annual market cap
stayed the same
from Dec. 2023 (kr4,225.52 Mil) to Dec. 2024 (kr4,225.52 Mil) but then
increased
from Dec. 2024 (kr4,225.52 Mil) to Dec. 2025 (kr30,507.89 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Q-linea AB's Enterprise Value for Today is kr99.53 Mil.
Q-linea AB (CHIX:QLINEs) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Q-linea AB Market Cap Related Terms
Q-linea AB Market Cap Historical Data
* Premium members only.
The historical data trend for Q-linea AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:QLINES vs ABT, SYK, MDT: Market Cap Comparison
For the Medical Devices subindustry, Q-linea AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Q-linea AB Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Q-linea AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Q-linea AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Q-linea AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Q-linea AB (CHIX:QLINES) has a Market Cap of kr319.29 Mil as of Jul. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Q-linea AB and its competitors. According to the industry distribution chart, Q-linea AB ranks #601 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 69.2%.
Is Q-linea AB's Market Cap too high?
Q-linea AB's current Market Cap is kr319.29 Mil. Based on the distribution chart, Q-linea AB ranks #601 out of 868 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Q-linea AB has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Q-linea AB ranks #601 out of 868 companies for Market Cap. This places Q-linea AB in the lower half of its industry. The industry median Market Cap is 120.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.30, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Q-linea AB and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Q-linea AB's current Market Cap is kr319.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Q-linea AB (CHIX:QLINES) has a current Market Cap of kr319.29 Mil. The stock's GF Value™ is kr1,981.69, compared to a current price of kr1,610.00 — trading 18.8% below its estimated fair value. The current Market Cap is kr319.29 Mil. Q-linea AB's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Q-linea AB (CHIX:QLINES), the current Market Cap is kr319.29 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Q-linea AB (CHIX:QLINES) Overvalued in 2026?
Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued.
The current stock price of kr1,610.00 is trading 18.8% below its estimated GF Value™ of kr1,981.69.
Key valuation signals for CHIX:QLINES:
Market Cap: kr319.29 Mil
GF Value™: kr1,981.69 vs. price of kr1,610.00 (18.8% below fair value)
No single metric tells the full story. See the CHIX:QLINES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
68GF Score
Get the complete analysis for CHIX:QLINES
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:QLINES has been successfully added to your 
